Heidi Cuthbert

Gossamer Bio (NASDAQ:GOSS) announced topline results from its pivotal PROSERA Phase 3 Study on Monday, February 23, 2026.

Axsome Therapeutics (NASDAQ:AXSM) reported a surge in full-year 2025 revenue on Monday, fueled by the rapid commercial scaling of its depression and sleep disorder treatments.

Merck & Co. (NYSE: MRK), known as MSD outside the U.S. and Canada, announced a significant restructuring of its Human Health division on Monday, February 23, 2026.

Gilead Sciences (NASDAQ:GILD) announced Monday it has entered into a definitive agreement to acquire Arcellx (NASDAQ:ACLX), moving to take full control of a high-potential cell therapy pipeline for multiple myeloma.

Grayscale said XRP is among the most discussed digital assets after bitcoin in conversations between financial advisors and their clients.

Pro-Ripple lawyer and US Senate candidate John Deaton has rejected calls to pardon former FTX chief executive Sam Bankman-Fried, dismissing recent claims that the exchange was solvent before its 2022 collapse.

Investor capital is rotating from newly launched crypto tokens into publicly listed crypto companies as more than 80% of 2025 token launches trade below their token generation event price, according to DWF Labs.

The official TRUMP and MELANIA meme coins have erased an estimated $4.3 billion in retail investor wealth, leaving roughly 2 million holders underwater more than a year after launch.

Nuix (ASX:NXL) announced its financial results for the half-year ended Dec. 31, 2025, headlined by gains in annual contract value and a successful shift toward its modern platform.

Tesla (NASDAQ:TSLA) unveiled a new, lower-priced version of its Cybertruck in the U.S. on Thursday, while simultaneously cutting the price of its top-tier "Cyberbeast" by $15,000.